Developing a contemporary community clinic for patients with heart failure with preserved ejection fraction within the current National Health Service model

INTRODUCTION: The diagnostic and therapeutic arsenal for heart failure with preserved ejection (HFpEF) has expanded. With novel therapies (eg, sodium-glucose co-transporter 2 inhibitors) and firmer recommendations to optimise non-cardiac comorbidities, it is unclear if outpatient HFpEF models can ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Patrick, Long, Thomas, Smith, Jessica, Kuehl, Michael, Mahdy, Tarek, Banerjee, Prithwish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639156/
https://www.ncbi.nlm.nih.gov/pubmed/36332941
http://dx.doi.org/10.1136/openhrt-2022-002101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639156/
https://www.ncbi.nlm.nih.gov/pubmed/36332941
http://dx.doi.org/10.1136/openhrt-2022-002101

Ejemplares similares